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Abstract
Background: This study was performed to evaluate anti-inflammatory and immune modulating properties of the
probiotic, spore-forming bacterial strain: Bacillus coagulans: GBI-30, (PTA-6086, GanedenBC30TM). In addition, cell
wall and metabolite fractions were assayed separately to address whether biological effects were due to cell wall
components only, or whether secreted compounds from live bacteria had additional biological properties. The
spores were heat-activated, and bacterial cultures were grown. The culture supernatant was harvested as a source
of metabolites (MTB), and the bacteria were used to isolate cell wall fragments (CW). Both of these fractions were
compared in a series of in vitro assays.
Results: Both MTB and CW inhibited spontaneous and oxidative stress-induced ROS formation in human PMN cells
and increased the phagocytic activity of PMN cells in response to bacteria-like carboxylated fluorospheres. Both
fractions supported random PMN and f-MLP-directed PMN cell migration, indicating a support of immune
surveillance and antibacterial defense mechanisms. In contrast, low doses of both fractions inhibited PMN cell
migration towards the inflammatory mediators IL-8 and LTB4. The anti-inflammatory activity was strongest for CW,
where the PMN migration towards IL-8 was inhibited down to dilutions of 10
10.
Both MTB and CW induced the expression of the CD69 activation marker on human CD3
- CD56
+ NK cells, and
enhanced the expression of CD107a when exposed to K562 tumor cells in vitro.
The fractions directly modulated cytokine production, inducing production of the Th2 cytokines IL-4, IL-6, and IL-10,
and inhibiting production of IL-2.
Both fractions further modulated mitogen-induced cytokine production in the following manner: Both fractions
enhanced the PHA-induced production of IL-6 and reduced the PHA-induced production of TNF-alpha. Both frac-
tions enhanced the PWM-induced production of TNF-alpha and IFN-gamma. In addition, MTB also enhanced both
the PHA- and the PWM-induced expression of IL-10.
Conclusion: The data suggest that consumption of GanedenBC30TM may introduce both cell wall components
and metabolites that modulate inflammatory processes in the gut. Both the cell wall and the supernatant possess
strong immune modulating properties in vitro. The anti-inflammatory effects, combined with direct induction of IL-
10, are of interest with respect to possible treatment of inflammatory bowel diseases as well as in support of a
healthy immune system.
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An intact and properly functioning gastrointestinal (GI)
system is of paramount importance in the maintenance
of optimal human health. The GI tract plays important
roles in nutrient absorption and assimilation, providing
a protective barrier against invasion by harmful organ-
isms, and training the immune system to distinguish
between harmful and harmless substances. To maximize
the absorption of nutrients obtained from the diet, the
luminal side of the GI tract is organized into finger-like
projections called villi. The surface area of the average
GI tract has been calculated to be 300 m
2 and is lined
by a single layer of epithelial cells. As a protective bar-
rier against abrasion and to minimize contact of this
epithelium by harmful organisms the GI tract is lined by
a mucus layer consisting of polysaccharides. Beneath the
epithelial cell layer are highly structured and active ana-
tomical areas of our immune system, including the
lamina propria and Peyer’s patches. In order for the
immune system to provide meaningful protection, it
needs to be able to carefully discriminate between a
large number and variety of antigens (proteins capable
of inducing an immune response) that the GI tract is
exposed to [1,2].
An optimal state of health can be adversely affected
when any of these functions are compromised and can
result in deficiencies due to malabsorption, infection
and inflammation due to invasion by opportunistic
organisms, or even autoimmune disease due to inap-
propriate immune system response to self. These pertur-
bations can lead to a state of chronic low-grade
inflammation. Chronic inflammation and gut microbiota
imbalances are thought to be contributing factors to a
variety of common diseases that have become serious
public health problems including, but not limited to car-
diovascular disease, obesity, cancer, diabetes, arthritis,
depression, and inflammatory bowel diseases [3-7].
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microbes, which is many times greater than the entire
number of cells comprising the human body. Since
these organisms can be either commensal or pathogenic,
the human body has had to develop effective strategies
to maintain a balance such that the opportunistic patho-
genic organisms are kept to a minimal number, thus
limiting the inflammation and damage they can induce
[2].
Probiotics are defined as viable microorganisms that
can populate the GI tract in an active state and extend
beneficial qualities to the host [8]. They play an impor-
tant role in the health of the GI system by altering the
environment, limiting the growth of pathogenic organ-
isms, synthesizing nutrients, and increasing energy har-
vesting from the food we ingest. Species such as
Lactobacillus, Bifidobacteria,a n dBacillus coagulans are
lactic acid producing bacteria, which can lower the pH,
creating an environment that is not hospitable to many
yeasts and bacterial species. Probiotic bacteria can also
secrete antimicrobial compounds that are harmful to
pathogenic organisms and thus limit their growth [9].
These bacteria also synthesize nutrients that are benefi-
cial to the host and other beneficial gut organisms such
as vitamin K2 and a variety of the B vitamins including
folate and B12.
The immune system and the GI system are integrally
c o n n e c t e d[ 2 ] .I ti sa tt h i si n t e r f a c eb e t w e e nt h el u m e n
of the gut and the lamina propria that the immune sys-
tem must make decisions regarding which substances
are harmless and which are potentially deleterious. The
foods we consume as well as opportunistic and benefi-
cial microbes that occupy our gut are full of antigenic
peptides and proteins capable of inducing immune
responses. One function of the mucosal immune system
is to mount an inflammatory immune response, when
appropriate, to eliminate pathogens or to induce toler-
ance for those substances and organisms that are advan-
tageous, such as food nutrients and probiotic bacteria
[10]. Probiotic bacteria affect the adaptive and innate
immune system by interacting with numerous cell types
along the mucosa including B cells, T cells, regulatory T
cells, monocytes, macrophages, NK cells and dendritic
cells [9,11]. The immune response is determined by the
environment, including cytokines, as well as the absence
versus presence of inflammatory mediators.
Commonly consumed probiotic bacteria such as the
Lactobacillus species are very sensitive to normal phy-
s i o l o g i c a lc o n d i t i o n sl i k et h ev e r yl o wp Ho ft h es t o -
mach, bile salts, and high temperatures. This creates
challenges for the delivery of these bacteria to the intes-
tines by oral consumption as well as challenges in man-
ufacturing, shipping and storage conditions [12-14].
On the contrary, some strains of Bacillus coagulans
are able to survive the extremes of heat, acidity of the
stomach and bile acids. These characteristics make it an
ideal probiotic due to the greater shelf-life stability and
survivability to the intestines when consumed. Bacillus
coagulans transiently occupies the gut for just a few
days without repeated oral consumption. Spores of
Bacillus subtilis, which is very closely related to Bacillus
coagulans, have been shown to germinate and colonize
the gastrointestinal tract in a murine model for a limited
period [15]. The safety of long-term oral consumption
of GanedenBC30TM (GBC30), was recently demon-
strated [16].
The subject of this study is a proprietary strain of
Bacillus coagulans (GBI-30, PTA-6086). In Asia, Bacillus
coagulans is used in a number of commercially available
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natto (a fermented soy food) along with Bacillus subtilus
[16,17]. GBC30, supplied by Ganeden Biotech, Inc.
(Mayfield Heights, OH, USA) is a lactic acid producing
bacteria that has been used as an ingredient in func-
tional foods, dietary supplements, and medical foods.
GBC30 is a gram-positive spore-forming rod that is
aerobic to microaerophilic in nature and is manufac-
tured as a pure cell mass consisting solely of a proprie-
tary B. coagulans strain. Recent clinical studies have
shown the efficacy of oral consumption of GBC30 for
alleviating symptoms of irritable bowel syndrome [18]
and inducing an increased immune response to viral
challenge [19].
One aspect of probiotic research that has been ques-
tioned is whether the entire effect is due to cell wall
components, or whether there are further advantages
provided by live, metabolically active probiotic bacteria
[20]. Much has been documented on the interaction of
specific bacterial cell wall components with Toll-like
receptors (TLRs) on immune cells’, typically inducing
innate immune defense mechanisms [21,22]. Gram
negative bacteria predominantly engage the TLR-4
receptor through interaction with lipopolysaccharide
present in the bacterial cell wall. Conversely, gram posi-
tive bacteria engage the TLR-2 receptor via interaction
with lipoteichoic acids present in the bacterial cell wall
[23]. However, the mechanism of action for atypical cell
wall components, as well as the metabolites secreted by
these organisms needs further elucidation [24]. Bacillus
coagulans is not a typical inhabitant of the human gas-
trointestinal tract. Limited, but emerging research has
been published on Bacillus coagulans as a probiotic and
to the best of our knowledge this is the first study to
investigate the differential effects of the isolated cell wall
components compared with the bacterial metabolites. A
broad panel of in vitro bioassays was perfomed to
explore potential effects of GBC30 on different aspects
of the immune system. This involved the study of both
peripheral blood mononuclear cells (PBMC) and poly-
morphonuclear (PMN) cells.
Methods
Reagents
The following buffers and reagents were obtained from
Sigma-Aldrich (St. Louis, MO): The T-cell mitogen Phy-
tohemagglutinin (PHA), phosphate-buffered saline
(PBS), RPMI-1640 culture medium, hydrogen peroxide
30% solution, Histopaque 1077 and 1119, fibronectin
0.1% from bovine plasma, and dimethyl sulfoxide
(DMSO) 99.9%. The following reagents were obtained
from Molecular Probes (Eugene, OR): 5-(and-6)-chloro-
methyl-2’,7’-dichlorodihydrofluorescein diacetate, acetyl
ester (CM-H2DCFDA), FluoSpheres® carboxylate-
modified microspheres 1.0 μm, and CyQuant®. The cyto-
metric bead array for human Th1/Th2 cytokine kit II,
CD69-FITC, CD25-FITC, CD107a-FITC, CD56-PE and
CD3-PerCP were obtained from BD Biosciences (San
Jose, CA). Sodium Azide (NaN3)w a so b t a i n e df r o m
LabChem Inc. (Pittsburgh, PA). Low-binding 200 μm
zirconium beads were obtained from OPS Diagnostics
(Lebanon, NJ) and 0.2 μm cellulose acetate filters from
Whatman (Florham Park, NJ). Multiscreen plates with
3.0 μm pore size for cell migration were obtained from
Millipore (Bedford, MA). The Bacillus coagulans strain
(GanedenBC
30™) was obtained from Ganeden Biotech
Inc. (Mayfield Height, OH).
Preparation of Bacillus Coagulans Supernatant and Cell
Wall Fractions
A sample of 2.0 g of GBC30 spores was placed into 25
mL PBS and heated at 70°C for 30 minutes. Spores were
then centrifuged at 2400 rpm for 5 minutes, PBS
removed and spores re-suspended in RPMI-1640 culture
medium. The culture was incubated at 37°C for 2 days.
Preparation of GBC
30 culture supernatant (MTB) as a
source of GBC30 metabolites: Following an initial spin
at 3000 rpm for 15 minutes, the supernatant was
removed and centrifuged further at 3500 rpm for 20
minutes. The supernatant was then filtered twice
through a 0.2 μm cellulose acetate syringe filter and 250
μL aliquots stored at -20°C.
Preparation of GBC30 cell wall fragments (CW): The
bacterial pellet from the initial centrifugation of the 2-day
culture was processed through multiple bead milling and
freeze/thaw cycles. In brief, the pellet was resuspended in
4 mL of PBS and 4 mL of 200 μm low-binding zirconium
beads were added. One cycle of bead milling consisted of
60 one-second pulses of the bacteria/bead mixture on a
vortex mixer. Five of these cycles were performed. The
supernatant was removed from the beads and spun at high
speed in 1.5 mL microcentrifuge tubes. The pellets were
combined and re-suspended in 1 mL PBS and processed
through 3 freeze/thaw cycles and placement in a sonica-
tion bath for an hour. The final solution was filtered
through a 0.2 μm cellulose acetate filter and 250 μL ali-
quots stored at -20°C.
Purification of peripheral blood mononuclear cells (PBMC)
and polymorphonuclear (PMN) cells
Healthy human volunteers between the ages of 20 and
50 years served as blood donors upon informed consent,
as approved by the Sky Lakes Medical Center Institu-
tional Review Board (FWA 2603). Freshly drawn periph-
eral venous blood samples in sodium heparin were
layered onto a double-gradient of Histopaque 1119 and
1077, and centrifuged for 25 minutes at 2400 rpm. The
upper, PBMC-rich and lower PMN interfaces were
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and washed twice with 10 mL PBS without calcium or
magnesium by centrifugation at 2400 rpm for 10 min-
utes. The PBMC fraction contains the natural killer
(NK) cell population and was used for testing of NK cell
activity as well as lymphocyte proliferation and cytokine
production.
Phagocytosis assay
Evaluation of phagocytic activity was performed using
human PMN cells. The choice of particles for phagocy-
tosis was carboxylated FluoroSpheres (Molecular
Probes, Eugene OR), due to their surface treatment
that decreases nonspecific binding and facilitates
uptake by phagocytes. These beads fluoresce in the yel-
low-green spectrum (505/515 nm). An aliquot of 0.05
mL FluoroSpheres was removed from the stock bottle
into a 1.5 mL microcentrifuge tube and washed twice
in PBS. FluoroSpheres were then re-suspended in 7.5
mL RPMI 1640. PMN cells were plated into 96-well
plates in RPMI-1640 at a concentration of 2 × 10
6
cells/mL. Ten microliters of 10-fold serial dilutions of
MTB or CW were added to test wells in quadruplicate,
and PBS was added to control wells in quadruplicate.
The plate was immediately centrifuged, and the super-
natant removed. The cells were re-suspended in RPMI-
1640 containing FluoroSpheres, and then incubated for
2 minutes with FluoroSpheres with continuous pipet-
ting. The phagocytic activity was stopped by adding
PBS with 0.02% sodium azide. Cells were washed twice
in PBS with sodium azide to remove beads not
ingested by the cells. Samples were transferred into
vials for flow cytometry, ensuring the continued pre-
sence of sodium azide. Samples were acquired by flow
cytometry immediately (FacsCalibur, Becton-Dickinson
San Jose, CA). The analysis was performed using the
FlowJo software (TreeStar Inc., Ashland OR). During
analysis, electronic gating for the PMN population was
performed using the forward and side scatter proper-
ties. The relative amount of phagocytosis within the
PMN population in each sample was evaluated by the
mean fluorescence intensity (MFI) for the green fluor-
escence. The MFI (green) for the untreated samples
showed the relative amount of phagocytosis in the
absence of MTB and CW. The MFI (green) for the
MTB and CW treated samples were compared to
untreated samples. Phagocytosis samples were assayed
in triplicates and experiments repeated three times
with PMN cells from three different donors.
Reactive Oxygen Species (ROS) production by PMN cells
The production of ROS by PMN cells was tested as
described previously [25]. Parallel samples of PMN cells
were incubated at 37°C, 5% CO2 for 20 minutes, either
untreated or with test products over a range of 10-fold
serial dilutions (1:10, 1:100, 1:1000). The precursor dye
DCF-DA, which becomes brightly green fluorescent
upon exposure to free radicals, was prepared by adding
0.18 mL DMSO to a 0.05 mg aliquot of DCF-DA. A
working solution of DCF-DA was then prepared by add-
ing 0.01 mL stock to 10 mL PBS. The PMN cells were
washed three times in PBS and then re-suspended in
the DCF-DA working solution and incubated for 1 hour
at 37°C. All samples, except for the untreated control
samples, were then exposed to 167 mM H2O2 for a per-
iod of 45 minutes to induce ROS production. Samples
were washed twice in PBS to remove the peroxide, and
transferred to vials for flow cytometry. The DCF-DA
fluorescence intensity in untreated versus H2O2-chal-
lenged cells was analyzed by flow cytometry. Data was
collected in quadruplicate and experiments performed 3
times using cells derived from 3 different donors. The
relative amount of ROS formation in PMN cells was
evaluated by green fluorescence intensity.
PMN cell random migration and chemotactic migration
towards three chemo-attractants: f-MLP, IL-8 and
Leukotriene B4
The PMN cell is a highly active and migratory cell
type. The differential effect on PMN cell migration
towards the bacterial peptide formyl-Met-Leu-Phe (f-
MLP) and two different inflammatory chemo-attrac-
tants IL-8 and Leukotriene B4 (LTB4) were tested, as
described previously [26]. The following experimental
model was performed in quadruplicate in order to
obtain data significance. Cells were incubated with 10-
fold serial dilutions of GBC30 supernatant or cell wall
fractions for 10 minutes in a polystyrene round-bottom
tube before plating commenced. During this time the
Millipore trans-well (3.0 μm pore size) migration plate
was coated with 50 μg/mL Fibronectin for a period of
30 minutes. Chemoattractants and RPMI 1640 were
then added to the appropriate bottom chamber wells
of the trans-well migration plate in a volume of
150 μL: f-MLP (10 nM), Interleukin-8 (10 μg/mL), and
Leukotriene B4 (10 nM). Fibronectin was removed
from the top wells by aspiration before plating of cells.
Fifty microliters of cells (1 × 10
6/mL) were plated in
the top chambers, and the top chamber plate was then
lowered into the bottom plate and allowed to incubate
overnight at 37°C. Quantification of the relative
amount of migrated cells was performed by fluorescent
CyQuant® staining of the cells that had accumulated in
the bottom chambers. Fluorescence intensity was
quantified in a Tecan Spectrafluor fluorescence plate
reader. Samples were assayed in triplicate or quadru-
plicate and experiments repeated at least 3 times with
cells from different donors.
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Freshly isolated PBMC were distributed in a sterile U-
bottom 96-well culture plates (NUNC, Denmark) and
treated with serial dilutions of test products [27,28]. For
activation of natural killer (NK) and natural killer T
(NKT) cells the incubation time was 18 hours. Cells
were transferred to V-bottom 96-well plates (NUNC
Denmark) and washed in IF buffer (PBS containing 1%
bovine serum albumin and 0.02% sodium azide). Cells
were re-suspended in 0.05 mL IF buffer and monoclonal
antibodies were added in previously established optimal
quantities (CD3-PerCP, CD56-PE, CD69-FITC, and
CD25-FITC: 8 μL/sample), and incubated in the dark at
room temperature for 10 minutes. The cells were
washed twice with an additional 0.15 mL of PBS with
0.02% azide. Following centrifugation and aspiration of
the supernatant, the cells were re-suspended in 0.05 mL
PBS with 0.02% azide and transferred to 5 mL polystyr-
ene round-bottom tubes each containing 0.4 mL of 1%
formalin. Samples were stored in the dark and acquired
by flow cytometry within 24 hours using a FACSCalibur
flow cytometer (Becton-Dickinson, San Jose CA). Analy-
sis was performed using the FlowJo (Tree Star Inc., Ash-
land OR) software. Samples were assayed in duplicate
and experiments repeated three times with cells derived
from three different donors.
Externalization of CD107a on NK cells in response to
K562 tumor cells
The CD107a marker is constitutively expressed on the
interior of lysosomes, and transiently expressed onteh
cell surface of NK cells that are actively engaged in the
killing of transformed cells [29]. Freshly purified human
peripheral blood mononuclear cells (PBMC) re-sus-
pended in RPMI 1640 were used for this assay. The
c e l l sw e r ep l a t e da t2×1 0
5/well in round-bottomed 96-
well micro-assay plates, and treated with serial dilutions
of the test products in triplicate. Negative control wells
in triplicate were left untreated. In addition, three wells
containing PBMC alone and K562 cells alone served as
negative controls for baseline CD107a expression. 1 ×
10
6 K562 cells, an NK-cell sensitive tumor cell line
widely used in NK cell cytotoxicity studies, were added
to wells containing PBMC with product and untreated
PBMC. The two cell types were loosely pelleted by a
brief 30-second centrifugation at 2400 rpm followed by
incubation at 37°C for 45 minutes. Cells were trans-
ferred to V-bottom microtiter plates for processing and
staining. Cells were stained with CD3-PerCP, CD56-PE
and CD107a-FITC. The expression of CD107a on the
NK cells was determined by flow cytometry. The CD3
negative, CD56 positive NK cells were differentiated
from the K562 cells based on forward and side scatter
properties, and from other lymphocytes by electronic
gating on CD3
-,C D 5 6
+ cells, followed by evaluation of
fluorescence intensity for CD107a. Samples were assayed
in triplicate and experiments repeated three times using
cells derived from three different donors.
Modulation of proliferation and cytokine production in
response to PHA and PWM
Freshly purified PBMC re-suspended in RPMI 1640 sup-
plemented with 10% fetal calf serum, L-glutamine (2
mM), penicillin (100 U/mL) and streptomycin (100 mg/
mL) were plated in a U-bottom cell culture plate at a
volume of 180 μL at a concentration of 1 × 10
6/mL.
Next, 20 μL of 10-fold serial dilutions of MTB and CW
were added to the individual wells in triplicate. In a par-
allel set of wells, the combinatorial effect of MTB and
CW with known mitogens was tested. Mitogens were
added at a concentration of 5 μL of PWM (200 μg/mL)
and 4 μLo fP H A( 2μg/mL) to initiate proliferation.
The plate was sealed with parafilm and was incubated at
37°C, 5% CO2 for 5 days. After 5 days the cells were
transferred to a flat-bottom black 96-well plate and the
relative cell numbers in each culture well quantified by
CyQuant® staining and a Tecan Spectrafluor fluores-
cence plate reader. Samples were assayed in triplicate
and experiments repeated three times with cells derived
from three different donors.
Supernatants from the 5-day lymphocyte proliferation
cultures were harvested and relative levels of the 6 cyto-
kines: IL-2, IL-4, IL-6, IL-10, TNF-a,a n dI F N - g were
measured using a flow cytometry-based bead array kit
(CBA human Th1/Th2 cytokine kit II, BD Biosciences,
San Jose, CA). Samples were assayed for the 1:100 dilu-
tion of MTB and CW. Samples were tested in duplicate
a c c o r d i n gt ot h em a n u f a c t u r e r ’s specifications, and data
acquired immediately by flow cytometry, using a Facs-
Calibur flow cytometer (Becton-Dickinson San Jose,
CA). The analysis was performed using the FlowJo soft-
ware (TreeStar Inc., Ashland, OR).
Statistical analysis
Statistical significance was tested using Student’st - t e s t
with p < 0.05 indicating a statistically significant and p <
0.01 a highly statistically significant difference between
two data sets. Analyses were performed using Microsoft
Excel. Only statistically significant p values are reported.
Results
Inhibition of Formation of Reactive Oxygen Species (ROS)
by PMN cells
The PMN cell is involved in innate immune defense
mechanisms, including the formation of ROS as part of
both anti-bacterial and pro-inflammatory reactions.
Treatment with complex natural products can cause sig-
naling of pro- as well as anti-inflammatory mechanisms,
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formation.
Both MTB and CW showed a clear inhibition of the
spontaneous formation of reactive oxygen species in
PMN cells (Figure 1A). The effect of CW showed a con-
sistent inhibition of ROS formation across all doses
tested, whereas the effect of MTB showed stronger
anti-inflammatory effect at the lowest doses tested. The
presence of MTB (1:1000) reduced spontaneous ROS
formation by 20% (p < 0.004). CW (1:1000) showed a
similar effect on lowering ROS formation (p < 0.005). At
the 1:10 dilution of CW this effect was even stronger,
resulting in a nearly 30% reduction in spontaneous ROS
formation (p < 0.0008).
Treatment of PMN cells with MTB and CW before
exposing the cells to oxidative stress and resulting ROS
formation showed that both MTB and CW inhibited the
H2O2-induced ROS formation (Figure 1B). MTB (1:100)
and CW (1:100) reduced ROS formation by 15% and
this reduction was statistically significant for CW (p <
0.03).
Effect on PMN phagocytic activity
Phagocytosis of microbial particles is an important part
of the innate immune response. It is a rapid process,
and the effect of a test product on enhancing this cellu-
lar function can be almost immediate. Phagocytosis was
measured by how well PMN cells engulfed carboxylated
fluorospheres. The mean fluorescence intensity (MFI) of
phagocytic cells was then evaluated by flow cytometry.
Exposure of PMN cells to MTB at the 1:10 dilution
increased phagocytosis by 40% (Figure 2A). Exposure of
PMN cells to CW at the 1:10 dilution increased phago-
cytosis by 25% (p <0 . 0 2 ) .F i g u r e2 As h o w st h eo v e r a l l
increase for the entire population of PMN cells, where
some cells are phagocytic and others remain non-phago-
cytic. Figures 2B and 2C show the comparison of an
untreated PMN cell to a PMN cell exhibiting increased
phagocytosis following exposure to CW. Further dilu-
tions of both products resulted in reduced PMN phago-
cytosis (p < 0.05) (data not shown).
Differential effect on PMN cell random migration and
chemotactic migration towards three chemo-attractants:
f-MLP, IL-8, and Leukotriene B4 (LTB-4)
The PMN cell is a highly active and migratory cell type
that plays a major role in immune surveillance. The
migratory behavior of this cell type is divided into at
least two types: a) random migration and b) directed
migration. Random migration is part of normal immune
surveillance, whereas directed migration happens
towards specific chemoattractants.
The effects of MTB and CW on both types of migra-
tion were tested in parallel. Furthermore, the directed
migration was tested towards three distinctly different
chemotactic compounds: i) bacterial peptide f-Met-Leu-
Phe (f-MLP); ii) the inflammatory cytokine Interleukin-8
(IL-8); and iii) Leukotriene B4 (LTB4).
Both fractions of GBC30 induced the random migra-
tion of PMN cells. MTB (1:10) increased the random
migration by 300% (p < 0.05), and CW (1:10) increased
the random migration by 25% (p < 0.006) (Figure 3A).
A distinct dose-dependent effect was seen with treat-
ment of cells with MTB but not CW.
Figure 1 The inhibition of formation of Reactive Oxygen Species (ROS) was evaluated in human polymorphonuclear (PMN) cells.T h e
DCF-DA mean fluorescence intensity in the cells was proportional to the oxidative damage. Untreated cells served as a baseline for oxidative
activity in the absence of oxidative stress. The presence of BC fractions MTB and CW led to inhibition of the spontaneous ROS production in the
cultures (A). H2O2 was used to induce oxidative stress in the cultures. Cultures treated with H2O2 in the absence of GBC30 fractions served as a
positive control for ROS formation. Cultures treated with GBC30 fractions MTB and CW in the presence of oxidative stress showed reduced ROS
formation compared to cultures treated with H2O2 alone (B). Data reflect averages of cultures performed in quadruplicate for each test
condition. The data shown are representative of three independent experiments performed on PMN cells from different donors.
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the bacterial peptide f-MLP, implicating a support of
anti-bacterial defense mechanisms (Figure 3B). Once
again a dose-dependent response was seen following
MTB treatment of cells. At the 1:10 dilution, MTB
showed a 200% enhancement of f-MLP directed migra-
tion that was highly statistically significant (p <0 . 0 0 0 5 ) .
A 25% increase following CW treatment (1:10) was also
statistically significant (p < 0.04).
Both MTB and CW reduced the IL-8 directed migra-
tion. Because we saw a strong reduction in IL-8 directed
migration of PMN cells treated with low doses of CW
and also saw some reduction with low doses of MTB, a
dose study of IL-8 directed PMN migration with much
lower doses of both MTB and CW was performed. As
shown in Figure 3C, a reduction in IL-8 directed PMN
migration was demonstrated at all dilutions of CW. This
effect of CW was strongest at the 10
10 dilution, where
Figure 2 Human polymorphonuclear (PMN) cells were evaluated for phagocytic activity, measured by the uptake of green-fluorescent
beads.( A) Flow cytometry analysis showed an increase in mean fluorescence intensity (MFI) of PMN cells treated with either MTB or CW.
Microscopy showed that the level of bead uptake by an untreated PMN cell (B) was increased in PMN cells treated with CW (C). Photographs
were taken at 600× magnification and the bar drawn in figure 2C represents 5 uM. The data shown are representative of PMN cells assayed in
triplicate for each test condition.
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treatment of PMN cells at low doses also reduced IL-8
directed migration but not as much as CW. An interest-
ing pattern of IL-8 directed PMN migration inhibition
was seen with both MTB and CW. Neither product
demonstrated a linear dose curve but rather intermedi-
ate doses (10
4 to 10
8)o fb o t hM T Ba n dC Ws h o w e d
less inhibition of IL-8 directed migration compared to
higher or lower doses.
Both MTB and CW demonstrated a dose-dependent
reduction in PMN migration towards LTB4 (Figure 3D).
The 1:1000 dilution of CW inhibited migration by 60%.
Cells treated with 1:1000 and 1:10000 dilutions of MTB
also showed anti-inflammatory effects but these were
not statistically significant.
Induction of the CD69 activation marker on Natural Killer
cells
Natural Killer (NK) cells are involved in our primary
defense mechanisms against transformed cells and
viruses. These cells travel in our blood stream in a state
of rest, but can be immediately activated to a) kill can-
cer cells by either cell contact or secretion of cytotoxic
c o m p o u n d ss u c ha sp e r f o r i na n dg r a n z y m e ,b )p r o l i f e r -
ate, and c) secrete substances that attract other cells
into the site. In order to investigate a possible effect of
MTB and CW on NK cell activation, we examined
changes in expression of the NK activation cell surface
marker CD69. The increased expression of this marker
has been associated with an increased cytotoxic activity
of NK cells [30].
Both MTB and CW showed a clear dose-dependent
induction of the expression of CD69 on NK cells (Figure
4A). This increase was statistically significant for the
1:400, 1:1600 and 1:6400 dilutions of both MTB and
CW (p < 0.05). At the 1:400 dilution, CD69 expression
was increased by 32% (p < 0.05) for MTB, and by 36%
for CW (p < 0.006).
Am i l di n c r e a s ei nC D 2 5e x p r e s s i o nw a ss e e no nN K
cells treated with a 1:100 dilution of MTB. No changes
Figure 3 Effects of GBC30 fractions on human PMN migration were evaluated using Transwell migration plates.( A) Both MTB and CW
treated PMN cells showed increased random migration behavior. (B) PMN cells treated with MTB or CW showed increased migratory behavior in
response to the bacterial peptide f-MLP. (C) PMN chemotactic migration towards the cytokine IL-8 was decreased in the presence of MTB and
CW. Extremely low doses of MTB and CW were tested for effects on IL-8 directed PMN cell migration. The cell wall fraction CW triggered
inhibition of PMN cell migration towards IL-8 down to dilutions of 10
-10. The metabolite fraction MTB showed similar but weaker inhibition
across the same dose range. (D) PMN chemotactic migration towards the inflammatory mediator LTB4 was decreased by both the cell wall
fraction MTB and the metabolite fraction CW, indicating an anti-inflammatory effect. The graphs show the averages and standard deviations of
each culture condition performed in triplicate. The data shown are representative of three experiments performed on cells from different donors.
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comparing untreated cells to those treated for 18 hours
with either MTB or CW (data not shown).
Externalization of CD107a on NK cells in the presence of
K562 tumor cells
One of the functions of NK cells is to kill tumor cells
and virus-infected cells via cell-cell contact and by
secretion of substances such as perforin. During this
process, the CD107a receptor expressed on the interior
of granules in the cytoplasm of NK cells is transiently
brought to the cell surface. Thus, the transient CD107a
expression on NK cells is a measure of their cytotoxic
activity by secretion of cytotoxic substances. Figure 4B
shows the change in mean fluorescence intensity (MFI)
of CD107a expression on natural killer cells that have
been exposed to tumor cells, with or without the addi-
tion of MTB or CW. Both MTB and CW show a mild
increase in CD107a cell surface expression, with CW
having the strongest effect at the 1:200 dilution, however
the effect did not reach statistical significance.
Effects on lymphocyte proliferation
With the question of immune support always comes the
need to prove that a product would not on its own trig-
ger exaggerated immune reactions. As part of a standard
safety testing of natural products, we tested whether the
test products had mitogenic potential, that is, whether
they induce cell division in healthy human lymphocytes.
Simultaneous to the test of mitogenic potential, we
tested whether the test products had an effect on cells
responsible for the adaptive immune defense, that is, T
and B lymphocytes.
The GBC30 fractions were tested in serial dilutions in
the absence and presence of mitogens. Two mitogens
were tested in parallel: Phytohemagglutinin (PHA),
which is a T cell mitogen that induces T cell prolifera-
tion, and Pokeweed Mitogen (PWM), which requires the
collaboration of T cells, B cells and monocytes in the
culture. Supernatants from the same cultures were pro-
cessed for cytokine levels (see below).
Neither MTB nor CW had a mitogenic effect on lym-
phocyte proliferation following five days incubation at
37°C with product and culture media (data not shown).
Both MTB and CW showed a reduction in lymphocyte
proliferation in the presence of PHA and PWM. This
reduction was statistically significant for both MTB and
CW (p < 0.02) (data not shown).
Effects on cytokine production
A flow cytometry-based Th1/Th2 cytokine bead array
f o rt h e6c y t o k i n e sI L - 2 ,I L - 4 ,I L - 6 ,I L - 1 0 ,T N F - a and
INF-g was used to evaluate the levels of cytokines pre-
sent in the supernatants from 5-day lymphocyte prolif-
eration cultures. Phytohemagglutinin (PHA) was used to
induce T cell proliferation, and Pokeweed Mitogen
(PWM) was used to induce T and B lymphocyte prolif-
eration in a process that requires the collaboration of T
cells, B cells and monocytes in the culture. Comparisons
were made between untreated PBMC versus PBMC cul-
tured in the presence of 1:100 dilutions of either MTB
or CW, with and without PHA and PWM (Figure 5A-
F). Untreated PBMC cells were cultured under identical
conditions as MTB and CW treated PBMC cultures and
cytokine levels in the untreated cultures used as a base-
line for comparison to MTB and CW treated cultures.
Figure 4 Effects of the metabolite fraction MTB and cell wall fraction CW on NK cell activation status and cytotoxic activity was
evaluated using human PBMC.( A) Both MTB and CW fractions induced the expression of the activation marker CD69 on CD3 negative, CD56
positive NK cells in a dose-dependent manner. The effect was statistically significant for the 1:400 dilution of both MTB and CW. (B) Expression of
CD107a on NK cells pretreated with MTB or CW showed a mild increase over baseline. The graphs show the averages and standard deviations
of each culture condition performed in triplicate. The data shown are representative of three experiments performed on cells from different
donors.
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Page 9 of 14Figure 5 The effects of the metabolite fraction (MTB) and cell wall fraction (CW) on cytokine production were evaluated on human
PBMC cultures.( A) Treatment of PBMC with MTB and CW resulted in reduced IL-2 production. There was no effect on mitogen-induced IL-2
production. (B) Treatment of PBMC with MTB and CW resulted in increased IL-4 production. There was no effect on mitogen-induced IL-4
production. (C) Treatment of PBMC with MTB and CW resulted in a strong increase in IL-6 production. Both MTB and CW further enhanced the
PHA-induced IL-6 production. In contrast, neither MTB nor CW modulated the PWM-induced IL-6 production. (D) Treatment of PBMC with MTB,
and to a lesser extent CW, resulted in an increased IL-10 production. MTB but not CW further enhanced the PHA-induced as well as the PWM-
induced IL-10 production. (E) Both MTB and CW treatment of PBMC resulted in a mild reduction in TNF-a production, both in the absence of
mitogens, and in the presence of PHA. In contrast, co-stimulation of PBMC with PWM and either MTB or CW resulted in a strong increase in
TNF-a production. (F) Very slight increases in IFN-g cytokine levels were seen following MTB or CW treatment in the absence of mitogens or
presence of PHA. In contrast, co-stimulation of PBMC with PWM and either MTB or CW resulted in a strong increase in IFN-g production.
Cytokine production in PBMC cultures was assayed in duplicate. The concentration of MTB and CW in the assayed cell cultures was 1:100.
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on the y axis indicates that treatment did not alter cyto-
kine production from baseline.
In the absence of mitogens, both MTB and CW treat-
ment of PBMC led to decreased IL-2 levels compared to
untreated PBMC (Figure 5A). This reduction was statis-
tically significant for MTB and CW (p < 0.02). No statis-
tically significant changes in IL-2 levels were observed
with MTB or CW treatment in the presence of either
mitogen, compared to mitogen treatment alone.
In the absence of mitogens, both MTB and CW treat-
ment of PBMC led to increased IL-4 levels compared to
untreated PBMC (Figure 5B). This increase was statisti-
cally significant for MTB (p < 0.03). No statistically sig-
nificant changes in IL-4 levels were observed with MTB
or CW treatment in the presence of either mitogen,
compared to mitogen treatment alone.
Both MTB and CW treatment of PBMC, in the
absence of mitogens, led to massive induction of IL-6
production (Figure 5C). The increase was highly statisti-
cally significant (p < 0.003). No statistically significant
changes in IL-6 levels were observed with MTB or CW
treatment in the presence of Pokeweed mitogen, com-
pared to Pokeweed mitogen treatment alone. The IL-6
induction by both MTB (p < 0.003) and CW (p < 0.002)
in the presence of PHA was found to be highly statisti-
cally significant.
Both MTB and CW treatment of PBMC, in the
absence of mitogens, led to induction of IL-10 produc-
tion (Figure 5D). The increase was statistically signifi-
cant (p < 0.02). PBMC treated with both MTB and PHA
led to higher IL-10 production (p < 0.008) than if cells
were treated with PHA alone. Treatment of PBMC with
MTB and PWM also led to an increase in IL-10 produc-
tion, however the data was not found to be statistically
significant. No statistically significant changes in IL-10
levels were observed with CW treatment in the presence
of either mitogen when compared to mitogen treatment
alone.
In the absence of mitogens, TNF-a production was
slightly lower than untreated PBMC in the presence of
both MTB and CW (Figure 5E). This mild reduction
was not statistically significant for either MTB or CW.
Treatment of PBMC with either MTB or CW in the
presence of PHA resulted in 2-fold decreases in TNF-a
expression that were statistically significant for both
MTB (p < 0.03) and CW (p < 0.006). In contrast, treat-
ment of PBMC with MTB and CW in the presence of
PWM resulted in strong increases in TNF-a levels. In
the presence of PWM, MTB treatment produced an 11-
fold increase (p < 0.03) and CW treatment a 22-fold
increase (p < 0.02).
In the absence of mitogens, INF-g levels increased in
response to treatment with both MTB and CW (Figure
5F). MTB produced a 41% increase (p <0 . 0 2 )a n dC W
resulted in a 54% increase (p < 0.02). Treatment of
PBMC with either MTB or CW in the presence of PHA
did not produce statistically significant changes in INF-g
expression. In contrast, treatment of PBMC with MTB
and CW in the presence of PWM resulted in 3-fold
(MTB) and 4-fold (CW) increases in INF-g levels, both
of which were statistically significant (p < 0.01).
Thus, when evaluating the overall effect on production
of all six cytokines, MTB induced an increased produc-
tion of the three Th2 cytokines IL-4, IL-6, and IL-10
(Figure 6A). Given the strong increase in IL-6 produc-
tion when cells were treated with MTB, a second graph
shows the data on the five cytokines where data on IL-6
were removed (Figure 6B). Simultaneously, a reduced
production of the two Th1 cytokines IL-2 and TNF-a
was seen. The increase in all three Th2 cytokines was
also seen for the CW fraction. However, Th1 cytokines
were not reduced, and IFN-g showed an increase above
untreated cells (Figure 6C-D).
Discussion
Inflammation, particularly chronic, low-grade inflamma-
tion, is an underlying phenomenon in many diseases,
including cardiovascular disease, obesity, arthritic condi-
tions, malignant transformation and progression of
tumor growth, Alzheimer’s disease, age-related cognitive
decline, and depression. This has brought nutritional
and nutraceutical anti-inflammatory products into focus,
as people look for non-pharmacological ways to stay
healthier longer [3].
Many types of bacterial cell wall components are
known to interact with Toll-Like Receptors (TLR) 2 and
4 and thereby trigger pro-inflammatory immune defense
reactions [31]. It was therefore particularly surprising
that the GBC30 cell wall fraction, CW, showed inhibi-
tory activity in several bioassays involving pro-inflamma-
tory types of immune reactions. These included
inhibition of ROS formation and reduced PMN cell che-
motactic migration in response to IL-8 and LTB4.
The GBC30 culture supernatant, MTB, showed similar
anti-inflammatory properties, although not quite as
potent as CW. There were sufficient data sets showing
distinctly different effects of MTB compared to CW.
These included a more robust effect on increasing pha-
gocytosis, enhancement of random and f-MLP directed
PMN migration and induction of the cytokine IL-10 in
5 day PBMC cultures. Conversely, NK cell activation,
demonstrated as an increase in CD69 expression, was
nearly identical following MTB or CW treatment, across
a broad dilution range. There were also multiple
instances where MTB demonstrated a dose-dependent
response that was not seen with CW, suggesting that
with MTB treatment unique effects of the metabolites
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seen. Therefore, we conclude that even though some
trace amount of cell wall components may be present in
MTB, they do not account for the overall biological
activity of MTB.
The effects of both GBC30 fractions were highly com-
plex, and were not limited to a simple anti-inflammatory
action. Both GBC30 fractions enhanced PMN cell ran-
dom migration, which is an important aspect of immune
surveillance. Both fractions also enhanced PMN cell
migration in response to the bacterial peptide f-MLP,
when used at higher doses. MTB treatment of cells had
a greater effect on enhancing random and f-MLP direc-
ted PMN migration than CW treatment and this effect
was dose dependent.
Both fractions induced the CD69 activation marker
on human CD3-negative, CD56-positive NK cells, and
also enhanced the transient expression of CD107a as
an indication of increased NK cell cytotoxicity in the
presence of transformed cells. The expression of
CD107a as a consequence of degranulation of NK cells
in the presence of NK sensitive tumor cells is
transient, as CD107a is rapidly recycled by re-uptake
into cytoplasmic granules containing cytotoxic sub-
stances. Thus, even though the CD107a data did not
reach statistical significance, it supports the evidence
of increased cytotoxic activity as indicated by increased
expression of CD69. CD69 expression on NK cells is
t h eo n l ya s s a yw h e r eM T Ba n dC Wp e r f o r m e dn e a r l y
identical.
Such observations are normally associated with a more
general activation of innate immune defense mechan-
isms, such as production of ROS, which was clearly not
the case for the GBC30 fractions. Both MTB and CW
inhibited spontaneous and H2O2-induced ROS forma-
tion. In the case of MTB, inhibition of spontaeous ROS
formation was strongest at the lowest dilution tested.
This interesting concentration-dependent effect of
responses was also seen for both MTB and CW with
regard to the migratory behavior of PMN cells in
response to 3 different chemotactic stimuli. This sug-
gests a complex immune response dependent on the
concentration of the different BC30 fractions assayed.
At high concentrations, a pro-inflammatory response is
Figure 6 The direct and dose-dependent effect of GBC30 fractions on Th1/Th2 cytokine production, in the absence of other stimuli, is
shown. The increase in production of the Th2 cytokines IL-4, IL-6, and IL-10, and composite effect on Th1 cytokines IL-2, IFN-g, and TNF-a,i s
shown for the metabolite-rich fraction MTB (A, B) and the cell wall fraction CW (C, D). In the graphs B and D, the data from IL-6 were removed
to better show the changes in production of the other 5 cytokines.
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response predominates.
The effects on cytokine profile were tested in several
ways, where both the direct effect, as well as the syner-
gistic effects with other known lymphocyte activating
compounds was studied. The products directly affected
the cytokine levels in vitro by increasing the production
of the Th2 cytokines IL-4 and IL-10. The shift towards
Th2 cytokine production reflects support of adaptive
immunity and antibody production, including sIgA
secretion, which may enhance immune defense mechan-
isms along the gut mucosa [32]. The products may also
affect important regulatory mechanisms affecting how
the immune system reacts to food-borne microbes and
antigens, such as induction of oral tolerance [33]. The
products may have direct immune modulating effects on
immune cells in lamina propria and Peyer’s patches,
affecting local and systemic cytokine levels and thus
potentially affecting inflammatory conditions at loca-
tions unrelated to the gut environment.
A greater increase in IL-10 production occurred in
cultures treated with MTB compared to cultures treated
with CW. In the presence of the mitogens PHA or
PWM, only MTB treatment produced an increase in IL-
10 above baseline. IL-10 has an anti-inflammatory role
in the gut and the consumption of IL-10 producing
transgenic bacteria has shown efficacy in the treatment
of Crohn’s disease [34]. This suggests that consumption
of GBC30 may also have a beneficial effect on condi-
tions of chronic intestinal inflammation such as Crohn’s
disease and ulcerative colitis.
Both GBC30 fractions strongly induced production of
IL-6 in PBMC cultures. IL-6 is not a simple pro- or
anti-inflammatory cytokine, but helps to regulate inflam-
mation. This regulatory cytokine has pleiotropic func-
tions that are tissue-specific and dependent upon the
physiological context [3]. The effects of IL-6 are influ-
enced by whether it is present acutely or chronically.
Thus, further evaluation of IL-6 levels in people con-
suming GBC30 is needed, in healthy individuals, indivi-
duals experiencing acute infection, in those with chronic
inflammatory conditions, insulin resistance, and
endothelial dysfunction. Based on the complexity of the
in vitro effects of both GBC30 fractions, we suggest that
consumption of the probiotic strain may show protec-
tive effects in both acute and chronic conditions.
A mild reduction of IL-2 and TNF-a was seen, along
with an increase in IFN-g production. The pro-inflam-
matory functions of TNF-a and IFN-g are undisputed;
however IL-2 has complex and opposing roles during
the induction and termination of inflammatory
responses. In contrast to the direct anti-inflammatory
effect on cytokine profile, GBC30 strongly enhanced
responses to the known stimulus Pokeweed mitogen
(PWM), which requires the collaboration of macro-
phages and different lymphocyte subsets. The increase
in IFN-g in PWM-treated cultures following treatment
with MTB and CW is of interest regarding the role of
IFN-g producing dendritic cells in mucosal immunity
against orally acquired pathogens [35]. This suggests
that GBC30 compounds may enhance the response to
invading pathogens in, for example, Peyer’s Patches,
where different cell types including dendritic cells colla-
borate on producing innate and adaptive immune
defense reactions.
Conclusions
The complex actions of both GBC30 fractions include
nti-inflammatory effects, while also supporting key
aspects of innate immune defense mechanisms. If some
or all of the effects observed in vitro can also potentially
take place when GBC30 replicates in the intestinal
environment, this could have important implications,
not only for protection of the host from potentially
pathogenic bacteria, but even more importantly, for con-
trolling local inflammatory processes and protecting
epithelial integrity, which then allows proper separation
of gut lumen, and proper nutrient assimilation and anti-
gen presentation to the immune system. The data sug-
gest that further clinical work should be initiated to
evaluate the effect of consumption of GBC30 as well as
the MTB and CW fractions on the control of inflamma-
tory reactions in vivo, while simultaneously supporting
anti-bacterial, anti-viral, and anti-tumor defenses in vivo.
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